Colgate-Palmolive Company (NYSE:CL) registered a -5.22% decrease, still its new closing price is 3.50% up from the company’s 1 year high of 74.54.It posted -4.81% losses in previous 5 sessions and is now the subject of 17 analysts who together assign a hold rating on stock. 0 of Wall Street analysts have an underperform rating; the 0 sells versus 2 buy or better ratings. The 20 stock analysts following this company have an average price target at $71.73, with individual PT in the $63.00-$81.00 range. The shares moved at $64.68, implying that brokerage firms see shares gaining about 1.68% in twelve months time.
Colgate-Palmolive Company (CL) SEC Form 4 News
The stock is getting much attention these days as insiders are offloading shares while they posted a -0.59% fall year to date. A Chief Technology Officer at Colgate-Palmolive Company (CL) offloaded shares in a transaction closed on Tuesday January 17, 2017. Verduin Patricia sold 3,833 shares in the company at $65.99 each and collected $252,001 in proceeds. Verduin Patricia now owns 58,147 shares in the company after this transaction. A CLO and Secretary in the company, Daniels Jennifer, disclosed a transaction on Monday January 09, 2017 that ended up generating $57,001 from the sale of 868 shares at $66.62 per share.
Colgate-Palmolive Company (NYSE:CL) Upcoming Results on Tap
Colgate-Palmolive Company will next provide financial results for the March 2017 quarter. Stock analysts expect it to report per-share earnings of $0.68 in that period. Sales during the quarter are predicted to arrive at $3.85 billion.
Earnings surprise history: Last quarter, the company posted approximately $3.72 billion in revenue and EPS of $0.75. The mean forecast was for $3.87 billion and $0.75 a share, respectively. One quarter earlier, revenue for the stock was at $3.87 billion, with earnings at $0.73/share.
Colgate-Palmolive Company (CL) Brokerage Update
Colgate-Palmolive Company (CL) is in BofA/Merrill’s research list so their analyst rating change is noteworthy. These shares were upgraded to Buy from Neutral by BofA/Merrill, according to news reported on Monday September 12, 2016.Another important research note was issued by Exane BNP Paribas on Friday July 29, 2016.The firm downgraded CL to Neutral from Outperform. Over the last six months and over the last three months, the shares of Colgate-Palmolive Company (CL), have changed -10.70% and -8.71%, respectively.
